Shengli Meng.jpg
Shengli Meng 孟胜利

Deputy Director, Wuhan Institute of Biological Products, Research Centre, Sinopharm Group


Mr. Shengli Meng was Doctor of Immunology at Wuhan Institute of Biological Products from 2004-2010.  From 2010 to now, he has been the Deputy Director of Wuhan Institute of Biological Products.


He participated in the development of "2019-NCOV inactivated vaccine”.  Publications include articles and books for international and domestic magazines.


Mr. Meng is also an editorial board member of international Journal of Biological Products; evaluation expert of Wuhan Science and Technology Bureau; expert of Chinese biological quality management; and has more than 10 years of experience in virus and vaccine related research. He is also familiar with the development progress and technical path of domestic vaccine.



重点研究成果:参与开发 “2019-nCov灭活疫苗”




Copyright © 2020 Nomura

This website is the sole property of Nomura. No part of this website may be reproduced in any form of by any means - electronic, mechanical, photocopying, recording or otherwise - without the prior written permission of Nomura.